News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
450,271 Results
Type
Article (24124)
Company Profile (160)
Press Release (425987)
Section
Business (125091)
Career Advice (487)
Deals (20603)
Drug Delivery (39)
Drug Development (79120)
Employer Resources (43)
FDA (12593)
Job Trends (9326)
News (234719)
Policy (18803)
Tag
Academia (1700)
Alliances (33634)
Alzheimer's disease (1241)
Approvals (12531)
Artificial intelligence (138)
Bankruptcy (144)
Best Places to Work (8210)
Biotechnology (122)
Breast cancer (181)
Cancer (1325)
Cardiovascular disease (100)
Career advice (423)
CAR-T (94)
Cell therapy (269)
Clinical research (64560)
Collaboration (439)
Compensation (219)
COVID-19 (2016)
C-suite (97)
Data (1371)
Diabetes (145)
Diagnostics (4980)
Earnings (47599)
Events (71857)
Executive appointments (346)
FDA (13198)
Funding (388)
Gene therapy (172)
GLP-1 (446)
Government (2284)
Healthcare (13784)
Infectious disease (2090)
Inflammatory bowel disease (115)
IPO (10998)
Job creations (1503)
Job search strategy (385)
Layoffs (258)
Legal (2303)
Lung cancer (195)
Lymphoma (94)
Manufacturing (143)
Medical device (9266)
Medtech (9266)
Mergers & acquisitions (9840)
Metabolic disorders (354)
Neuroscience (1550)
NextGen Class of 2024 (3895)
Non-profit (2437)
Northern California (1551)
Obesity (179)
Opinion (119)
Parkinson's disease (93)
Patents (78)
People (36961)
Phase I (20752)
Phase II (28786)
Phase III (20852)
Pipeline (485)
Postmarket research (2068)
Preclinical (7454)
Radiopharmaceuticals (235)
Rare diseases (233)
Real estate (2886)
Regulatory (15410)
Research institute (1831)
Southern California (1339)
Startups (2384)
United States (12769)
Vaccines (400)
Weight loss (102)
Date
Last 7 days (530)
Last 30 days (2149)
Last 365 days (29925)
2024 (29798)
2023 (33363)
2022 (41434)
2021 (43287)
2020 (39944)
2019 (30884)
2018 (23290)
2017 (24008)
2016 (21915)
2015 (25667)
2014 (18537)
2013 (13916)
2012 (14574)
2011 (14995)
2010 (14067)
Location
Africa (370)
Arizona (89)
Asia (27458)
Australia (5348)
California (3432)
Canada (1149)
China (271)
Colorado (149)
Connecticut (166)
Europe (62627)
Florida (429)
Georgia (114)
Illinois (254)
Indiana (171)
Japan (79)
Maryland (471)
Massachusetts (2588)
Michigan (104)
Minnesota (182)
New Jersey (931)
New York (922)
North Carolina (639)
Northern California (1551)
Ohio (112)
Pennsylvania (770)
South America (490)
Southern California (1339)
Texas (506)
Utah (91)
Washington State (351)
450,271 Results for "4g clinical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Humhealth Unveils Remote Patient Monitoring With Advanced 4G Device Configuration and 4G Watch
Humhealth, a leading provider of innovative remote care solutions, has the capability to integrate with an advanced 4G Telehealth Gateway Hub and 4G vital monitoring devices.
May 1, 2024
·
3 min read
Deals
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 5, 2024
G1 Therapeutics, Inc. today announced the grant of inducement stock options exercisable for 4,650 shares of G1’s common stock and 2,400 restricted stock units (RSUs) to one hired employee under the Amended and Restated G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (the “Amended and Restated 2021 Plan”).
June 5, 2024
·
2 min read
FDA Grants Clearance to Gel4Med: Breakthroughs in Wound Management with G4Derm and G4Derm Plus
Gel4Med, an innovative biomaterials company, is proud to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its first biosynthetic matrix products, G4Derm and G4Derm Plus.
October 23, 2023
·
3 min read
Biotech Beach
Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis
Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today unveiled the G4X™ Spatial Sequencer.
February 5, 2024
·
9 min read
Gel4Med Receives Recognition in Podiatry Today for their G4Derm Product Line as a Top 10 Innovations in Podiatry
July 9, 2024
·
4 min read
Policy
U.S. FDA Approves MedMira’s Advanced Reveal G4 Rapid HIV-1/2 Antibody Test
MedMira Inc. proudly announces the successful attainment of 510 clearance for the HIV-2 claim on the Reveal® G4 Rapid HIV-1/2 antibody test in the United States.
December 13, 2023
·
3 min read
Bio NC
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 01, 2023
G1 Therapeutics, Inc., a commercial-stage oncology company, announced the grant of inducement stock options exercisable for 4,700 shares of G1’s common stock and 2,300 restricted stock units to one hired employee under the Amended and Restated G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan.
December 1, 2023
·
2 min read
Press Releases
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 1, 2024
August 2, 2024
·
2 min read
Biotech Beach
Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform
Singular Genomics Systems, Inc. announced groundbreaking new products and capabilities at the Advances of Genome Biology and Technology conference in Orlando, Florida.
February 5, 2024
·
5 min read
Press Releases
Maze Therapeutics Announces Oversubscribed $115 Million Financing to Support Advancement of Clinical-Stage Programs and Future Pipeline
December 3, 2024
·
3 min read
1 of 45,028
Next
